Toxicology blood tests at Bids Chemist check for harmful metals like lead, mercury, and arsenic. Long-term exposure to these toxins can affect energy, memory, and organ health. Early detection helps prevent damage and allows for detox guidance, supporting your body’s natural recovery and maintaining safe, balanced wellbeing.
This test measures blood alcohol concentration for medical, legal, or occupational purposes. It can assess recent alcohol consumption, monitor abstinence programs, or evaluate potential alcohol-related metabolic effects. Blood is collected, and results provide a reliable measurement of alcohol levels at the time of testing. Understanding these results allows healthcare providers to provide counseling, guide treatment, ensure workplace safety, and detect potential alcohol misuse. Accurate measurement is important in clinical settings for patients undergoing treatment for alcohol dependence or in situations where monitoring is required for safety. Early detection and understanding of alcohol levels support better health outcomes, informed decision-making, and preventive care.
This test measures aluminium levels in the blood to detect potential toxic exposure from occupational sources, medications, or contaminated water. High levels may affect kidney, bone, or neurological function. Blood is drawn, and results are analysed to guide monitoring, treatment, and preventive measures. Early detection supports interventions to reduce toxicity, ensuring long-term health protection. Understanding aluminium levels helps healthcare providers implement safety strategies, lifestyle adjustments, and therapeutic plans to prevent complications and maintain organ function.
This test measures aluminium excretion in urine, reflecting ongoing exposure and total body burden. Urine is collected over a specific period, and results are interpreted to assess environmental or occupational exposure. Monitoring urinary aluminium helps healthcare providers take preventive measures, reduce toxicity, and protect kidney, bone, and neurological health. Patients gain insight into exposure risk and benefit from guidance to maintain safe aluminium levels through lifestyle and occupational interventions.
This test measures arsenic in the blood, which can indicate exposure to this toxic heavy metal through contaminated water, food, or occupational sources. High levels can affect the skin, liver, kidneys, and nervous system. Blood is collected and analysed to assess recent exposure, guide intervention, and prevent toxicity. Understanding arsenic levels allows healthcare providers to recommend lifestyle changes, environmental precautions, and treatment strategies, reducing long-term health risks associated with chronic exposure.
This test measures arsenic in urine, reflecting recent or ongoing exposure and helping evaluate the body’s ability to excrete this toxic metal. Urine is collected and analysed to monitor exposure levels. Early detection allows healthcare providers to implement preventive strategies, reduce environmental or occupational risk, and safeguard kidney, liver, and neurological health. Patients gain insight into exposure and can take steps to minimise health risks.
This test measures benzene levels, a toxic environmental chemical found in air pollution, cigarette smoke, and industrial settings. Blood is collected and analysed to assess exposure, which can affect bone marrow, blood cells, and increase cancer risk. Early detection allows healthcare providers to recommend environmental precautions, lifestyle adjustments, and monitoring to reduce toxicity. Patients gain insight into exposure risk and preventive strategies to protect long-term health.
This test measures cadmium in blood, a toxic heavy metal that can accumulate from environmental or occupational exposure. Blood is drawn, and elevated levels may affect kidneys, bones, or lungs. Understanding cadmium levels helps healthcare providers recommend environmental precautions, lifestyle changes, or medical interventions. Early detection supports long-term health protection and reduces the risk of chronic toxicity, empowering patients to take preventive actions in daily life or work.
This test measures carbamazepine levels, a medication used for epilepsy or mood disorders. Blood is drawn to assess therapeutic levels and prevent toxicity. Accurate monitoring ensures the medication is effective while minimising side effects. Results help healthcare providers adjust dosage safely, optimise treatment, and reduce risks of seizures or adverse reactions. Patients benefit from consistent symptom control, improved safety, and personalised care.
This test measures carbohydrate-deficient transferrin (CDT), a marker used to detect chronic alcohol consumption. Blood is collected, and elevated levels indicate prolonged alcohol intake. Results help healthcare providers identify potential alcohol misuse, monitor abstinence, and guide interventions. Patients benefit from early detection, preventive counseling, and support in managing alcohol-related health risks.
This test measures carboxyhaemoglobin, a compound formed when carbon monoxide binds to hemoglobin in the blood. Elevated levels indicate recent exposure to carbon monoxide, which can impair oxygen delivery and cause symptoms such as headache, dizziness, fatigue, or shortness of breath. Blood is collected and analysed to assess exposure severity. Early detection allows healthcare providers to intervene promptly, provide oxygen therapy if necessary, and advise on environmental or occupational safety measures. Patients benefit from understanding exposure risks, enabling them to take preventive actions and protect long-term cardiovascular and neurological health.
This test measures chromium levels in the blood, a trace element involved in glucose metabolism and insulin regulation. Blood is collected and analysed to detect deficiencies or exposure abnormalities. Abnormal levels may affect metabolic health, cardiovascular risk, or insulin sensitivity. Understanding chromium status allows healthcare providers to guide diet, supplementation, or lifestyle interventions. Patients benefit by optimising metabolic and cardiovascular health through informed interventions.
This test measures chromium levels in urine, reflecting recent exposure or excretion. Urine is collected over a specified period and analysed to assess environmental, occupational, or dietary intake. Abnormal levels can indicate excessi
This test measures cobalt levels in the blood, a trace element important for vitamin B12 metabolism and red blood cell production. Blood is collected and analysed to assess exposure, nutritional status, or toxicity risk. Elevated cobalt levels may result from occupational exposure, implants, or supplements, and can affect the heart, thyroid, or neurological function. Understanding cobalt status helps healthcare providers guide interventions, lifestyle adjustments, and monitoring. Patients benefit from insights into metal exposure, nutrient balance, and overall metabolic health, supporting preventive care and early detection of potential complications.
This test measures cobalt excretion in urine, reflecting recent exposure or body burden. Urine is collected and analysed to monitor cobalt levels over time. Abnormal levels may indicate occupational exposure, medical implants, or environmental sources, affecting organ function and overall health. Healthcare providers use results to guide preventive strategies, lifestyle adjustments, or treatment plans. Patients gain insight into metal exposure and take proactive measures to reduce toxicity and maintain long-term health.
This test measures cotinine in serum, a biomarker of nicotine exposure. Blood is collected and analysed to confirm recent tobacco use, monitor smoking cessation, or assess environmental exposure. Elevated levels help healthcare providers identify risk behaviors, guide counseling, and support interventions to reduce health risks. Patients benefit from awareness of nicotine exposure, enabling proactive steps toward cardiovascular, respiratory, and overall wellness.
This test measures digoxin levels, a medication used to treat heart conditions such as atrial fibrillation or heart failure. Blood is drawn to ensure therapeutic levels, monitor effectiveness, and prevent toxicity. Abnormal levels can cause symptoms like nausea, fatigue, or arrhythmias. Healthcare providers use results to adjust dosage safely and optimise cardiac function. Patients benefit from personalised treatment, reduced side effects, and improved heart health.
This profile tests for multiple drugs of abuse in a random urine sample, including alcohol, without chain-of-custody requirements. Urine is collected and analysed to detect the presence of controlled substances. Results help healthcare providers identify potential substance misuse, guide counseling, treatment, or workplace monitoring. Early detection supports patient safety, preventive interventions, and informed healthcare planning. Patients benefit by understanding substance exposure, managing risk, and receiving appropriate support for long-term health and wellness.
This test measures phenytoin (Epanutin) levels, a medication used to treat epilepsy. Blood is drawn to ensure therapeutic drug levels, prevent toxicity, and optimise seizure control. Abnormal levels may cause side effects such as dizziness, nausea, or ataxia. Results help healthcare providers adjust dosing safely and monitor patient response. Patients benefit from effective seizure management, reduced adverse effects, and personalised care.
This urine test screens for ketamine, a recreational or prescribed drug. Urine is collected and analysed to detect recent ketamine use. Results help healthcare providers monitor substance exposure, guide counseling, and ensure safe medical management. Patients benefit by understanding substance use, reducing risk of toxicity, and receiving support for safe medication use or behavioral interventions. Early detection promotes informed health decisions and overall safety.
This test measures lamotrigine levels in the blood, a medication used for epilepsy or bipolar disorder. Blood is drawn to ensure therapeutic levels, monitor effectiveness, and prevent toxicity. Results help healthcare providers adjust dosing safely and optimise treatment. Patients benefit by maintaining seizure control or mood stability, reducing side effects, and ensuring safe long-term management of their condition.
This test measures lead in the blood, a toxic heavy metal. Blood is collected and analysed to detect recent exposure from environmental, occupational, or household sources. Elevated lead levels can cause neurological, cardiovascular, or renal problems. Early detection allows healthcare providers to recommend treatment, lifestyle changes, or environmental modifications. Patients benefit by identifying exposure, preventing long-term health complications, and maintaining overall wellness.
This test measures lead excretion in urine, reflecting recent exposure or body burden. Urine is collected over a specific period and analysed to monitor environmental, occupational, or dietary intake. Abnormal results allow healthcare providers to guide interventions, reduce exposure, and prevent toxic effects. Patients benefit by understanding lead risk, implementing preventive measures, and supporting long-term health.
This test measures manganese levels in serum, an essential trace element involved in metabolism, bone formation, antioxidant defense, and enzyme function. Blood is collected to assess deficiency or excess, which may impact neurological, metabolic, or skeletal health. Abnormal levels can contribute to symptoms such as fatigue, cognitive changes, or bone abnormalities. Early detection allows healthcare providers to recommend dietary modifications, supplementation, or further investigation. Patients benefit by understanding manganese status, maintaining optimal metabolic and neurological health, and preventing long-term complications associated with deficiency or toxicity. Monitoring trace elements supports overall wellness, enzymatic balance, and proactive management of potential nutrient-related health issues.
This test measures mercury in blood, a toxic heavy metal that can affect neurological, renal, and cardiovascular systems. Blood is collected and analysed to identify recent exposure from environmental, occupational, or dietary sources. Early detection allows healthcare providers to recommend preventive measures, reduce exposure, and monitor potential toxicity. Patients benefit by understanding mercury levels, minimising health risks, and maintaining long-term wellness. Timely monitoring supports interventions to prevent neurological damage, kidney dysfunction, and cardiovascular complications, ensuring safe management of heavy metal exposure.
This test measures mercury excretion in urine, reflecting recent exposure and total body burden. Urine is collected and analysed to monitor heavy metal levels and evaluate risk. Abnormal results allow healthcare providers to implement interventions, reduce exposure, and prevent toxic effects. Patients benefit by understanding environmental or occupational exposure, making informed lifestyle adjustments, and protecting long-term neurological, renal, and cardiovascular health. Regular monitoring supports safe management of mercury and promotes overall wellness.
This test measures nickel levels in urine to assess recent or chronic exposure to this metal from occupational, environmental, or dietary sources. Urine is collected over a specified period and analysed for elevated nickel concentrations, which may lead to allergic reactions, respiratory issues, or kidney stress. Abnormal results allow healthcare providers to recommend lifestyle changes, reduce exposure, and monitor ongoing risk. Patients benefit by understanding their exposure, implementing preventive measures, and protecting long-term health. Regular monitoring supports early detection of toxicity, minimises complications, and promotes overall wellness. This test is particularly useful for individuals with occupational risk or environmental concerns.
This test measures olanzapine, an antipsychotic medication used for schizophrenia, bipolar disorder, or other psychiatric conditions. Blood is collected to determine therapeutic drug levels, monitor effectiveness, and prevent toxicity. Abnormal levels may lead to side effects such as sedation, weight gain, or metabolic changes. Healthcare providers use results to adjust dosing safely and optimise treatment. Patients benefit by maintaining symptom control, minimising side effects, and supporting long-term mental and physical health. Timely monitoring ensures personalised therapy, early detection of potential complications, and overall well-being.
This test measures phenytoin levels in blood, a medication used to control seizures. Blood is collected to ensure therapeutic levels, monitor efficacy, and prevent toxicity. Abnormal levels may cause side effects such as dizziness, fatigue, or ataxia. Healthcare providers use results to adjust dosing safely. Patients benefit by achieving optimal seizure control, minimising adverse effects, and maintaining long-term neurological health. Timely monitoring ensures safe and effective treatment.
This test measures salicylate levels in blood, typically from medications like aspirin or accidental exposure. Blood is collected and analysed to monitor therapeutic dosing, prevent toxicity, and detect overdose. Abnormal levels may cause symptoms such as nausea, dizziness, or bleeding. Healthcare providers use results to adjust treatment safely and ensure patient safety. Patients benefit by understanding medication levels, preventing side effects or toxicity, and maintaining overall health. Timely monitoring supports safe therapeutic use and long-term wellness.
This test measures tacrolimus (FK506) levels, an immunosuppressant used to prevent organ transplant rejection. Blood is collected and analysed to ensure therapeutic dosing, prevent toxicity, and monitor effectiveness. Abnormal levels may cause kidney damage, infections, or other side effects. Healthcare providers use results to adjust dosing safely and optimise treatment. Patients benefit by maintaining transplant health, minimising adverse effects, and supporting long-term wellness. Timely monitoring ensures safe, effective therapy and overall health.
This test measures thallium levels in blood to assess exposure, which may come from industrial or environmental sources. Blood is collected and analysed to detect toxicity. Abnormal levels may cause neurological, renal, or cardiovascular issues. Healthcare providers use results to guide interventions, reduce exposure, and monitor recovery. Patients benefit by understanding environmental risks, implementing preventive measures, and protecting long-term health. Timely testing supports safe management and overall wellness.
This test measures toluene in urine to detect environmental or occupational exposure. Urine is collected and analysed to assess risk of toxicity, which may affect neurological, hepatic, or renal function. Elevated levels allow healthcare providers to recommend exposure reduction, lifestyle adjustments, and monitoring. Patients benefit by understanding chemical exposure, minimising health risks, and supporting long-term wellness. Early detection enables preventive strategies, safe environmental practices, and maintenance of overall health.
This test measures valproic acid levels in blood, a medication commonly used to treat epilepsy, bipolar disorder, and migraine prevention. Blood is collected and analysed to ensure therapeutic drug levels, monitor efficacy, and prevent toxicity. Abnormal levels may cause side effects such as liver dysfunction, tremors, or gastrointestinal issues. Healthcare providers use results to adjust dosing safely, optimise therapy, and maintain seizure control or mood stability. Patients benefit by understanding medication levels, minimising adverse effects, and supporting long-term neurological and overall health. Timely monitoring ensures effective treatment, proactive safety management, and maintenance of wellness.
